SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-001563
Filing Date
2013-01-03
Accepted
2013-01-03 18:50:17
Documents
1
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4055
  Complete submission text file 0001209191-13-001563.txt   5469
Mailing Address C/O SPIROS DEVELOPMENT CORP II INC 7475 LUSK BLVD SAN DIEGO CA 92121
Business Address
MAST ERLE T (Reporting) CIK: 0001051411 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51665 | Film No.: 13509049

Mailing Address 10935 VISTA SORRENTO PARKWAY SUITE 250 SAN DIEGO CA 92130
Business Address 10935 VISTA SORRENTO PARKWAY SUITE 250 SAN DIEGO CA 92130 (858) 876-6500
Somaxon Pharmaceuticals, Inc. (Issuer) CIK: 0001339455 (see all company filings)

IRS No.: 200161599 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations